Literature DB >> 17976743

Activin as an anti-inflammatory cytokine produced by microglia.

Shuei Sugama1, Takato Takenouchi, Hiroshi Kitani, Masayo Fujita, Makoto Hashimoto.   

Abstract

The main objective of the present study was to determine if activin might inhibit microglial activation. In murine MG6 microglial cell cultures, lipopolysaccharide (LPS)-induced activation of these cells was mitigated by pretreatment with activin as assessed by compromised up-regulation of proinflammatory markers, including IL-18, IL-6 and iNOS. The suppressive effects of activin on microglial activation were similarly observed in rat brains administered with LPS into the lateral ventricle. The expression of activin mRNA was induced by treatment with LPS in both cell cultures and brains. Thus, activin might act as an anti-inflammatory cytokine produced by microglia, presumably modulating inflammation through an autocrine fashion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976743     DOI: 10.1016/j.jneuroim.2007.08.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Activin A: a potential therapeutic target for characterizing and stopping joint pain early in rheumatoid arthritis patients.

Authors:  Fei Dong; Xijing He
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 2.  Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer.

Authors:  Barbara Jung; Jonas J Staudacher; Daniel Beauchamp
Journal:  Gastroenterology       Date:  2016-10-20       Impact factor: 22.682

3.  Downstream mRNA Target Analysis in Neonatal Hypoxic-Ischaemic Encephalopathy Identifies Novel Marker of Severe Injury: a Proof of Concept Paper.

Authors:  A M Looney; C E Ahearne; B Hallberg; G B Boylan; D M Murray
Journal:  Mol Neurobiol       Date:  2016-12-12       Impact factor: 5.590

4.  Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.

Authors:  Stefan Jean-Pierre Haas; Xiaolai Zhou; Venissa Machado; Andreas Wree; Kerstin Krieglstein; Björn Spittau
Journal:  Front Mol Neurosci       Date:  2016-02-03       Impact factor: 5.639

5.  Expression and anti-inflammatory role of activin receptor-interacting protein 2 in lipopolysaccharide-activated macrophages.

Authors:  Qian Wu; Yan Qi; Na Wu; Chunhui Ma; Wenfang Feng; Xueling Cui; Zhonghui Liu
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

6.  Activin A is essential for neurogenesis following neurodegeneration.

Authors:  Andrea Abdipranoto-Cowley; Jin Sung Park; David Croucher; James Daniel; Susan Henshall; Sally Galbraith; Kyle Mervin; Bryce Vissel
Journal:  Stem Cells       Date:  2009-06       Impact factor: 6.277

7.  Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target.

Authors:  Jonas J Staudacher; Cemal Yazici; Timothy Carroll; Jessica Bauer; Jingbo Pang; Nancy Krett; Yinglin Xia; Annette Wilson; Georgios Papachristou; Andrea Dirmeier; Claudia Kunst; David C Whitcomb; Giamila Fantuzzi; Barbara Jung
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

Review 8.  Activin, neutrophils, and inflammation: just coincidence?

Authors:  Paschalis Sideras; Eirini Apostolou; Athanasios Stavropoulos; Alexandros Sountoulidis; Arianna Gavriil; Anastasia Apostolidou; Evangelos Andreakos
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.